Advertisement
Home Tags Diabetes: Drugs

Tag: Diabetes: Drugs

Metformin is associated with a lower risk of developing head and neck cancer in patients with diabetes

Metformin Linked to Lower Risk of Head, Neck Cancer

0
Diabetes patients treated with the drug less likely to develop oropharyngeal, nasopharyngeal cancers
Use of dipeptidyl peptidase-4 inhibitors in type 2 diabetes is tied to severe joint pain in some patients

FDA Warns of Joint Pain Tied to DPP-4 Inhibitors

0
Agency advises users with such symptoms to contact their doctor
Use of metformin during pregnancy doesn't impact the birth weight of infants born to obese mothers

Metformin in Pregnancy Shows No Effect on Infant Birth Weight

0
However, metformin can help to control women's blood glucose, researchers find
For patients with type 2 diabetes

Gastritis Linked to Metformin-Related GI Side Effects in T2DM

0
With metformin, mean score for gastrointestinal side effects higher for gastritis subjects over four weeks

FDA: Watch for Ketoacidosis With SGLT2 Inhibitors

0
Class of drugs includes canagliflozin, dapagliflozin, and empagliflozin
The use of dipeptidyl peptidase-4 inhibitors is not associated with an increased risk of hospitalization for community-acquired pneumonia

DPP-4 Inhibitors Not Tied to Pneumonia Hospitalizations

0
Findings among new users of antidiabetic drugs from 2007 to 2012
For patients with diabetes in the United States

Metformin Use Associated With Less CRC Risk in U.S. Population

0
Reduction in odds of colorectal cancer, even after adjustment for health care use